Mycobacterium bovis bacille Calmette-Guerin vaccination of cattle: Activation of bovine CD4+ and γδ TCR+ cells and modulation by 1,25-dihydroxyvitamin D3

Tuberculosis

Volumn 83, Issue 5, 2003, Pages 287-297

  Waters, W R ^a,b   Nonnecke, B J ^b   Foote, M R ^b   Maue, A C ^c   Rahner, I E ^a   Palmer, M V ^a   Whipple, D L ^a   Horst, R L ^b   Estes, D M ^c,d  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

^c University of Missouri   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

1,25 Dihydroxyvitamin D3; CD44; CD4+ cells; CD62L; Mycobacterium bovis BCG; Tuberculosis; T cells

Indexed keywords

ALLOANTIGEN; BCG VACCINE; CALCITRIOL; CD 62L ANTIGEN; CD4 ANTIGEN; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BCG VACCINATION; BEEF CATTLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; FLUORESCENCE ANALYSIS; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PURIFICATION; T LYMPHOCYTE SUBPOPULATION; ULTRASOUND;

EID: 0141506922     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-9792(03)00002-7     Document Type: Article

References (38)

1. Coleman JD, Cooke MM. Mycobacterium bovis infection in wildlife in New Zealand. Tuberculosis 2001;81;191-202.
2. Delahay RJ, Cheeseman CL, Clifton-Hadley RS. Wildlife disease reservoirs: the epidemiology of Mycobacterium bovis infection in the european badger (Meles meles) and other British mammals. Tuberculosis 2001;81:43-9.
3. Schmitt SM, Fitzgerald SD, Cooley TM, et al. Bovine tuberculosis in free-ranging white-tailed deer from Michigan. J Wildl Dis 1997;33:749-58.
4. Behr MA. Comparative genomics of BCG vaccines. Tuberculosis 2001;81:165-8.
5. Brandt L, Feino Cunha J, Weinreich Olsen A, et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 2002;70:672-8.
6. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. J Am Med Assoc 1994;271:698-702.
7. Berggren SA. Incidence of tuberculosis in BCG vaccinated and control cattle in relation to age distribution in Malawi. Br Vet J 1977;133:490-4.
8. Berggren SA. Field experiment with BCG vaccine in Malawi. Br Vet J 1981;137:88.
9. Doyle TM, Stuart P. Vaccination of cattle with BCG. Br Vet J 1958;114:3-10.
10. Buddle BM, de Lisle GW, Pfeffer A, Aldwell FE. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 1995;13:1123-30.
11. Griffin JF, Mackintosh CG, Slobbe L, Thomson AJ, Buchan GS. Vaccine protocols to optimise the protective efficacy of BCG. Tuber Lung Dis 1999;79:135-43.
12. Ametaj BN, Beitz DC, Reinhardt TA, Nonnecke BJ. 1,25-Dihydroxyvitamin D3 inhibits secretion of interferon-gamma by mitogen- and antigen-stimulated bovine mononuclear leukocytes. Vet Immunol Immunopathol 1996;52:77-90.
13. 3 on IFN-γ secretion by mononuclear leukocytes from nulliparous and postparturient dairy cattle. Int J Vit Nutr Res 2000;70:92-101.
14. + T celts to enhance the development of Th2 cells. J Immunol 2001;167:4974-80.
15. Manolagas SC, Provvedini DM, Tsoukas CD. Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 1985;43:113-22.
16. Muller K, Rieneck K, Hansen MB, Bendtzen K. 1,25-Dihydroxyvitamin D3-mediated suppression of T lymphocyte functions and failure of T cell-activating cytokines to restore proliferation. Immunol Lett 1992;34:37-44.
17. 3. Clin Diag Lab Immunol 2001;8:1204-12.
18. Nonnecke BJ, Franklin ST, Reinhardt TA, Horst RL. In vitro modulation of proliferation and phenotype of resting and mitogen-stimulated bovine mononuclear leukocytes by 1,25-dihydroxyvitamin D3. Vet Immunol Immunopathol 1993;38:75-89.
19. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001;19:93-129.
20. Adams JS, Ren SY, Arbelle JE, Shany S, Gacad MA. Coordinate regulation of nitric oxide and 1,25-dihydroxyvitamin D production in the avian myelomonocytic cell line HD-11. Endocrinology 1995;136:2262-9.
21. 3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986;57:159-360.
22. Chan TY. Vitamin D deficiency and susceptibility to tubercutosis. Calcif Tissue Int 2000;66:476-8.
23. Nicholson S, Bonecini-Almeida Mda G, Lapa e Silva JR, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996;183:2293-302.
24. 3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998;66:5314-21.
25. Burton JL Kehrli ME. Effects of dexamethasone on bovine circulating T lymphocyte populations. J Leukocyte Biol 1996;59:90-9.
26. Chen D, McKallip RJ, Zeytun A, et al. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of cd44 in activation-induced cell death. J Immunol 2001;166:5889-97.
27. Cadranel J, Garabedian M, Milleron B, Guillozo H, Akoun G, Hance AJ. 1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest 1990;85:1588-93.
28. D'Ambrosio D, Cippitelli M, Cocciolo MG, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998;101:252-62.
29. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000;164:2405-11.
30. Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000;164:4443-51.
31. Dailey MO. Expression of T lymphocyte adhesion molecules: regulation during antigen-induced T cell activation and differentiation. Immunology 1998;18:153-84.
32. Camp RL, Scheynius A, Johansson C, Pure E. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 1993;178:497-507.
33. Waters WR, Rahner TE, Palmer MV, Cheng D, Nonnecke BJ, Whipple DL. Expression of L-selectin (CD62L), CD44, and CD25 on activated bovine T cells. Infection and Immunity 2003;71:317-26.
34. Palmer HG, Gonzalez-Sancho JM, Espada J, et al., Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001;154:369-87.
35. Fujii K, Fujii Y, Hubscher S, Tanaka Y. CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells. J Immunol 2001;167:1198-203.
36. Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S. Interferon-γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 2000;192:117-22.
37. 3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985;134:3032-5.
38. Waters WR, Palmer MV, Pesch BA, Olsen SC, Wannemuehler MJ, Whipple DL. Lymphocyte subset proliferative responses of Mycobacterium bovis-infected cattle to purified protein derivative. Vet Immunol Immunopathol 2000;77:257-73.